Altria Group reaches analyst target price

What happened: On April 10, Bank of America (BofA) raised its price target on Altria Group (NYSE:MO) to $73, reiterating a 'Buy' rating, driven by increased EPS estimates. Altria, a dividend stock with a 57-year streak of annual increases, is expanding its oral nicotine pouch product, On!, nationwide. However, Altria's diversification efforts beyond cigarettes have had mixed results, with competition in the nicotine pouch market being stiff. On April 13, Altria's stock price briefly surpassed the average analyst 12-month target of $52.14, trading at $52.81 per share.

Market impact: The tobacco industry, particularly Altria, is experiencing a shift due to declining cigarette volumes and increased regulation. Altria's expansion into smoke-free products like On! is a strategic move to adapt to these changes, impacting its valuation and dividend yield. The company's high dividend yield (currently over 6%) makes it an attractive option for income-oriented investors, along with other blue-chip stocks like Verizon (VZ) and British American Tobacco (BTI).

What to watch next: Altria's Q1 2022 earnings report, scheduled for April 28, will provide insights into the company's progress in its smoke-free initiatives and its ability to maintain dividend growth. Additionally, regulatory developments regarding tobacco products and nicotine pouches, such as the FDA's fast-track approval programs, will continue to influence Altria's stock performance.